Breast Cancer: Biological and Clinical Progress: Proceedings of the Conference of the International Association for Breast Cancer Research, St. Vincent, Aosta Valley, Italy, May 26–29, 1991: Developments in Oncology, cartea 69
Editat de L. Dogliotti, A. Sapino, G. Bussolatien Limba Engleză Hardback – 31 mai 1992
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 1038.48 lei 6-8 săpt. | |
Springer Us – 5 noi 2012 | 1038.48 lei 6-8 săpt. | |
Hardback (1) | 1045.04 lei 6-8 săpt. | |
Springer Us – 31 mai 1992 | 1045.04 lei 6-8 săpt. |
Din seria Developments in Oncology
- 5% Preț: 341.81 lei
- 5% Preț: 364.61 lei
- 5% Preț: 345.71 lei
- 5% Preț: 1038.96 lei
- 5% Preț: 341.95 lei
- 5% Preț: 1066.34 lei
- 5% Preț: 3014.76 lei
- 5% Preț: 351.83 lei
- 5% Preț: 354.93 lei
- 5% Preț: 1342.85 lei
- 5% Preț: 355.66 lei
- 5% Preț: 349.24 lei
- 5% Preț: 1043.83 lei
- 5% Preț: 349.04 lei
- 15% Preț: 572.68 lei
- 5% Preț: 1350.30 lei
- 5% Preț: 1059.92 lei
- 5% Preț: 354.93 lei
- 5% Preț: 1341.13 lei
- 5% Preț: 685.05 lei
- 5% Preț: 675.70 lei
- 5% Preț: 1348.77 lei
- 5% Preț: 680.75 lei
- 5% Preț: 348.37 lei
- 5% Preț: 1347.90 lei
- 5% Preț: 1039.67 lei
- 5% Preț: 3632.63 lei
- 5% Preț: 1042.44 lei
- 5% Preț: 1050.42 lei
- 5% Preț: 1344.26 lei
- 5% Preț: 1363.11 lei
- 5% Preț: 1055.76 lei
Preț: 1045.04 lei
Preț vechi: 1100.04 lei
-5% Nou
Puncte Express: 1568
Preț estimativ în valută:
200.07€ • 216.77$ • 167.07£
200.07€ • 216.77$ • 167.07£
Carte tipărită la comandă
Livrare economică 12-26 decembrie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780792316558
ISBN-10: 079231655X
Pagini: 311
Ilustrații: XIX, 311 p.
Dimensiuni: 155 x 235 x 19 mm
Greutate: 0.64 kg
Ediția:1992
Editura: Springer Us
Colecția Springer
Seria Developments in Oncology
Locul publicării:New York, NY, United States
ISBN-10: 079231655X
Pagini: 311
Ilustrații: XIX, 311 p.
Dimensiuni: 155 x 235 x 19 mm
Greutate: 0.64 kg
Ediția:1992
Editura: Springer Us
Colecția Springer
Seria Developments in Oncology
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
I. Activation of Cellular Oncogenes.- 1. The Role of Oncogenes and Onco-Suppressor Genes in Human Breast Cancer.- 2. Expression of the MET Oncogene in Human Tumors.- 3. c-erbB-2, a Tyrosine Kinase Growth Factor Receptor and its Role in Breast Cancer.- 4. Mammary Morphogenesis and Oncogenes.- II. Polypeptides and Growth Factors Expression.- 5. Interdependence of Hormones and Growth Factors in Lobulo-Alveolar Development of the Mammary Gland and Tumorigenesis.- 6. The Role of Estrogen Regulated Secreted Proteins for Growth Regulation of Human Breast Cancer.- 7. The Prolactin-lnducible Protein / Gross Cystic Disease Fluid Protein (PIP/GCDFP-15): Genetic Analysis and Hormonal Regulation of Gene Expression.- III. Mammary Epithelium and Stroma in Vivo and in Vitro.- 8. Role of RAS Oncogene in Human Breast Cancer: an Experimental Approach.- 9. Interactions Between Malignant and Non-Malignant Components of the Breast.- 10. Involvement of Heparanase and Extracellular Matrix-Bound Fibroblast Growth Factor in Tumor Progression.- IV. Hormone Responsiveness and Oral Contraceptives.- 11. Estrogen and Progesterone Receptor Activity in Breast Cancer Cells.- 12. Oral Contraceptives and Breast Cancer: the Scope for a Hypothesis-Oriented Approach.- V. Risk Factors; Monitoring of Breast Cancer Progression and Regression.- 13. Benign Breast Disease: Links to Risk of Cancer.- 14. Proliferation Rate in Different Cell Types in Benign Breast Disease.- 15. Aspects of Cell Mediated Immunity in Monitoring Breast Cancer.- 16. New Approaches to the Study of Selenium’s Chemopreventive Properties.- VI. Biological Factors of Prognosis; the Metastatic Phenotype.- 17. Cell Kinetics as an Indicator for Prognosis and Therapy.- 18. Cathepsin D and Breast Cancer Metastasis: Biological and ClinicalSignificance.- 19. Diagnostic tools and prognostic factors in human breast cancer evaluated by morphological and immunohistochemical methods.- VII.Therapeutic Strategies in Breast Cancer Treatment.- 20. Oestrogen-Deprivation in Breast Cancer: Clinical and Experimental Observations.- 21. Polyamines and Growth Factors as Possible Targets for Antitumor Therapy in Breast Cancer.- 22. New Diagnostic Methods and Treatment Modalities in Breast Cancer.